HAMPS BIO LIMITED — Investor Relations & Filings

Hamps Bio Limited specializes in the development, manufacturing, and marketing of a broad spectrum of pharmaceutical formulations. The company’s product portfolio includes various dosage forms such as tablets, capsules, liquid orals, ointments, and injectables, covering therapeutic areas like anti-infectives, analgesics, cardiovascular, and gastrointestinal health. Utilizing advanced manufacturing infrastructure, the organization maintains compliance with international quality standards, including WHO-GMP certifications. The firm focuses on delivering high-quality, cost-effective medicinal solutions to a global clientele, supported by a robust supply chain and a commitment to research and development. Its operations are centered on enhancing patient outcomes through a diverse range of generic and specialized healthcare products.